1. Biological and physical approaches on the role of piplartine (piperlongumine) in cancer
    Tiago Henrique et al, 2020, Scientific Reports CrossRef
  2. Anticancer effects of piperine-free Piper nigrum extract on cholangiocarcinoma cell lines
    Potchanapond Graidist et al, 2020, Pharmacognosy Magazine CrossRef
  3. Piperlongumine inhibits TGF-β-induced epithelial-to-mesenchymal transition by modulating the expression of E-cadherin, Snail1, and Twist1
    Min-Ju Park et al, 2017, European Journal of Pharmacology CrossRef
  4. Blocking fatty acid–fueled mROS production within macrophages alleviates acute gouty inflammation
    Christopher J. Hall et al, 2018, Journal of Clinical Investigation CrossRef
  5. Overview of piperlongumine analogues and their therapeutic potential
    Peng Zhu et al, 2021, European Journal of Medicinal Chemistry CrossRef
  6. miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer
    Xiuting Hu et al, 2017, Cell Death & Disease CrossRef
  7. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
    Chitra Rajagopal et al, 2018, Pharmacological Research CrossRef
  8. Piplartine Analogues and Cytotoxic Evaluation against Glioblastoma
    Flávio da Nóbrega et al, 2018, Molecules CrossRef
  9. Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies
    Siva Jyothi Buggana et al, 2019, Computational Biology and Chemistry CrossRef
  10. Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer
    Sandeep Kumar et al, 2021, Molecular and Cellular Biochemistry CrossRef
  11. Repurposing of drugs as STAT3 inhibitors for cancer therapy
    Pathum S. Thilakasiri et al, 2021, Seminars in Cancer Biology CrossRef
  12. Piplartine (piperlongumine), oxidative stress, and use in cancer
    Daniel Pereira Bezerra, 2021, Cancer CrossRef
  13. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p
    Yawei Hu et al, 2021, Life Sciences CrossRef
  14. Detection of Janus-activated kinase-1 and its interacting proteins by the method of luminescent oxygen channeling
    Xin-Xin Guo et al, 2017, RSC Advances CrossRef
  15. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma
    Tianshu Liu et al, 2017, International Journal of Oncology CrossRef
  16. STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
    Milad Ashrafizadeh et al, 2020, Biology CrossRef
  17. The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer—A Review on In Vitro, In Vivo, and Clinical Studies
    Sylwia Nakonieczna et al, 2020, International Journal of Molecular Sciences CrossRef
  18. The promising potential of piperlongumine as an emerging therapeutics for cancer
    Dey Parama et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef
  19. Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
    Cinara O. D’Sousa Costa et al, 2017, Oncotarget CrossRef
  20. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
    Surya Kant Tripathi et al, 2020, Pharmacological Research CrossRef
  21. Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway
    Jinfeng Zhou et al, 2020, Toxicology in Vitro CrossRef
  22. The Synergistic Effect of Piperlongumine and Sanguinarine on the Non-Small Lung Cancer
    Marta Hałas-Wiśniewska et al, 2020, Molecules CrossRef
  23. Galangin Inhibits Gastric Cancer Growth Through Enhancing STAT3 Mediated ROS Production
    Xiaohui Liang et al, 2021, Frontiers in Pharmacology CrossRef